A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma
Phase of Trial: Phase I/II
Latest Information Update: 09 May 2018
At a glance
- Drugs GSK 3377794 (Primary) ; Cyclophosphamide; Fludarabine
- Indications Liposarcoma
- Focus Therapeutic Use
- Sponsors Adaptimmune
- 09 May 2018 According to an Adaptimmune media release, data from this trial will be presented at the American Society of Clinical Oncology 2018.
- 15 Mar 2018 Results assessing partial responses and stable disease in first four patients dosed published in an Adaptimmune Media Release.
- 15 Mar 2018 According to an Adaptimmune media release, data update from this and other study (NCT01343043: Synovial Sarcoma) will be presented at an upcoming congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History